Detalhe da pesquisa
1.
A novel pro-oxidant combination of resveratrol and copper reduces transplant related toxicities in patients receiving high dose melphalan for multiple myeloma (RESCU 001).
PLoS One
; 17(2): e0262212, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35120140
2.
U.S. Food and drug administration approval: rituximab in combination with fludarabine and cyclophosphamide for the treatment of patients with chronic lymphocytic leukemia.
Oncologist
; 16(1): 97-104, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21212432
3.
Impact of pre-operative serum C-reactive protein and cell-free chromatin levels on tumor aggressiveness and survival outcome in oral cavity squamous cell carcinoma.
Oral Oncol
; 114: 105078, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33183996
4.
Immune-related adverse events associated with immune checkpoint inhibitors: a call to action for collecting and sharing clinical trial and real-world data.
J Immunother Cancer
; 9(7)2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34215691
5.
Androgen receptor inactivation contributes to antitumor efficacy of 17{alpha}-hydroxylase/17,20-lyase inhibitor 3beta-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene in prostate cancer.
Mol Cancer Ther
; 7(8): 2348-57, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18723482
6.
Improved synthesis of histone deacetylase inhibitors (HDIs) (MS-275 and CI-994) and inhibitory effects of HDIs alone or in combination with RAMBAs or retinoids on growth of human LNCaP prostate cancer cells and tumor xenografts.
Bioorg Med Chem
; 16(6): 3352-60, 2008 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18166465
7.
Potent anti-prostate cancer agents derived from a novel androgen receptor down-regulating agent.
Bioorg Med Chem
; 16(7): 3519-29, 2008 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18316193
8.
Murine toxicology and pharmacokinetics of novel retinoic acid metabolism blocking agents.
Cancer Chemother Pharmacol
; 60(6): 899-905, 2007 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17345084
9.
VN/14-1 induces ER stress and autophagy in HP-LTLC human breast cancer cells and has excellent oral pharmacokinetic profile in female Sprague Dawley rats.
Eur J Pharmacol
; 734: 98-104, 2014 Jul 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-24726842
10.
U.S. Food and Drug Administration approval summary: brentuximab vedotin for the treatment of relapsed Hodgkin lymphoma or relapsed systemic anaplastic large-cell lymphoma.
Clin Cancer Res
; 18(21): 5845-9, 2012 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22962441
11.
Design, synthesis, and evaluation of novel mutual prodrugs (hybrid drugs) of all-trans-retinoic acid and histone deacetylase inhibitors with enhanced anticancer activities in breast and prostate cancer cells in vitro.
J Med Chem
; 51(13): 3895-904, 2008 Jul 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-18543902
12.
First pharmacophore-based identification of androgen receptor down-regulating agents: discovery of potent anti-prostate cancer agents.
Bioorg Med Chem
; 15(10): 3413-21, 2007 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17383188
13.
Retinoic acid metabolism blocking agents (RAMBAs) for treatment of cancer and dermatological diseases.
Bioorg Med Chem
; 14(13): 4323-40, 2006 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16530416